XPONENTIAL FITNESS INC-A (XPOF)

US98422X1019 - Common Stock

12.29  +0.05 (+0.41%)

After market: 12.29 0 (0%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to XPOF. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 20.4. This target is 65.99% above the current price.
XPOF was analyzed by 16 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about XPOF.
In the previous month the buy percentage consensus was at a similar level.
XPOF was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 12.2912.1219.8920.4037.80 - -1.38% 61.84% 65.99% 207.57%
Up and Down Grades
Date Firm Action Rating
2024-08-05 B. Riley Securities Maintains Neutral -> Neutral
2024-08-02 Roth MKM Maintains Buy -> Buy
2024-08-02 Raymond James Maintains Strong Buy -> Strong Buy
2024-08-02 Baird Maintains Neutral -> Neutral
2024-08-02 Piper Sandler Reiterate Neutral -> Neutral
2024-07-11 Piper Sandler Maintains Neutral -> Neutral
2024-06-18 Guggenheim Maintains Buy -> Buy
2024-05-13 Piper Sandler Maintains Neutral -> Neutral
2024-05-03 B. Riley Securities Maintains Buy -> Buy
2024-04-12 Stifel Maintains Buy -> Buy
2024-03-13 B of A Securities Maintains Neutral -> Neutral
2024-03-05 Stifel Maintains Buy -> Buy
2024-03-04 Citigroup Maintains Buy -> Buy
2024-03-01 Baird Maintains Neutral -> Neutral
2024-01-03 Piper Sandler Downgrade Overweight -> Neutral
2023-12-13 Stifel Upgrade Hold -> Buy
2023-11-15 Guggenheim Maintains Buy -> Buy
2023-11-08 Raymond James Maintains Strong Buy -> Strong Buy
2023-11-01 B of A Securities Downgrade Buy -> Neutral
2023-10-13 Stifel Initiate Hold
2023-09-15 Guggenheim Maintains Buy -> Buy
2023-08-16 Guggenheim Maintains Buy -> Buy
2023-08-04 Morgan Stanley Reiterate Overweight -> Overweight
2023-06-28 Roth MKM Maintains Buy
2023-06-28 Baird Maintains Neutral -> Neutral
2023-06-27 Baird Maintains Neutral
2023-05-08 Guggenheim Maintains Buy
2023-05-08 Morgan Stanley Maintains Overweight
2023-05-08 Citigroup Maintains Buy
2023-05-05 Raymond James Maintains Strong Buy